Pharming Q3 EPS $0.30 Beats $0.02 Estimate, Sales $117.600M Miss $117.733M Estimate

Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.02 by 1400 percent. This is a 200 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $117.600 million which missed the analyst consensus estimate of $117.733 million by 0.11 percent. This is a 20.86 percent increase over sales of $97.300 million the same period last year.